BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Steinebrunner N, Stein K, Sandig C, Bruckner T, Stremmel W, Pathil A. Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort. World J Gastroenterol 2018; 24(7): 852-861 [PMID: 29467555 DOI: 10.3748/wjg.v24.i7.852]
URL: https://www.wjgnet.com/1007-9327/full/v24/i7/852.htm
Number Citing Articles
1
JiHyun An, Dong Ah Park, Min Jung Ko, Sang Bong Ahn, Jeong-Ju Yoo, Dae Won Jun, Sun Young Yim. Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-AnalysisJournal of Personalized Medicine 2022; 12(9): 1517 doi: 10.3390/jpm12091517
2
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
3
Taghrid Mohamed Abdalla, Sameh M. Abdel Monem, Hosam M. Dawod. Value of Child-Turcotte-Pugh Score in Prediction of Treatment Response in “Difficult to Treat” Chronic HCV Cirrhotic PatientsOpen Journal of Gastroenterology 2019; 9(11): 211 doi: 10.4236/ojgas.2019.911024
4
Xinyan Ma, Lili Huang, Meijie Yu, Rui Dong, Yifan Wang, Hongbo Chen, Rongbin Yu, Peng Huang, Jie Wang. Dynamic Prediction of the Risk of Hepatocellular Carcinoma After DAA Treatment for Hepatitis C PatientsCancer Control 2025; 32 doi: 10.1177/10732748251316609